Michael Alifrangis - Infectious Diseases

Author Information

Michael Alifrangis is affiliated with the Center for Medical Parasitology, Department of Immunology and Microbiology at the University of Copenhagen, as well as the Department of Infectious Diseases at Copenhagen University Hospital in Copenhagen, Denmark. His research primarily focuses on infectious diseases, with a particular interest in malaria and its epidemiological factors, treatment efficacy, and genetic aspects of Plasmodium falciparum.

Research Contributions

Michael Alifrangis has made significant contributions to the field of infectious diseases, particularly in the study of malaria. His research includes the investigation of malaria trends and control strategies, the effectiveness and safety of antimalarial treatments, and the genetic variability of Plasmodium falciparum. His work is critical in understanding the dynamics of malaria transmission and developing effective control measures. Additionally, he has explored the impact of drug-resistant malaria on birth outcomes and the detection of malaria in pregnant women. His research also extends to the study of mosquito vectors and strategies to reduce their populations.

Aliases

Michael Alifrangis is also known by the aliases M Alifrangis and M. Alifrangis. These variations are used interchangeably in academic and research publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	4807
H-index	40
Total Paper Count	195

Publications:

Weight change during the first week of life and a new method for retrospective prediction of birthweight among exclusively breastfed newborns

DOI: 10.1111/aogs.14323

Year: 2022

Trends in malaria epidemiological factors following the implementation of current control strategies in Dangassa, Mali

DOI: 10.1186/s12936-022-04058-0

Year: 2022

Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial

DOI: 10.1186/s12879-022-07101-2

Year: 2022

Prevalence of asymptomatic malaria, submicroscopic parasitaemia and anaemia in Korogwe District, north-eastern Tanzania

DOI: 10.1186/s12936-021-03952-3

Year: 2021

Risk factors for occurrence and abundance of Aedes aegypti and Aedes bromeliae at hotel compounds in Zanzibar

DOI: 10.1186/s13071-021-05005-9

Year: 2021

Identification of Single-Nucleotide Polymorphisms in the Mitochondrial Genome and Kelch 13 Gene of Plasmodium falciparum in Different Geographical Populations.

DOI: 10.4269/ajtmh.21-0320

Year: 2021

Ultrasensitive qPCR-Based Detection of Plasmodium falciparum in Pregnant Women Using Dried Blood or Whole Blood Pellet Samples Processed through Different DNA Extraction Methods.

DOI: 10.4269/ajtmh.21-0496

Year: 2021

Reduced birth weight caused by sextuple drug resistant Plasmodium falciparum infection in early 2nd trimester.

DOI: 10.1093/infdis/jiab117

Year: 2021

Targeted elimination of species‐rich larval habitats can rapidly collapse arbovirus vector mosquito populations at hotel compounds in Zanzibar

DOI: 10.1111/mve.12525

Year: 2021

Ten years of monitoring malaria trend and factors associated with malaria test positivity rates in Lower Moshi

DOI: 10.1186/s12936-021-03730-1

Year: 2021

What is the Emergency Use Authorization (EUA)?

What Measures Can Individuals Take to Protect Themselves from Infectious Diseases?

What are the Symptoms of Lyme Disease?

What are the Symptoms of Rabies?

What is Plasmodium falciparum Malaria?

How Can Adverse Effects be Minimized?

How Long Do Pathogens Survive on Surfaces?

What are Apicomplexan Parasites?

How do Antimicrobial Resistance (AMR) Affect Mortality?

How do Bacteria Cause Diseases?

Partnered Content Networks

Relevant Topics